Aliceblue ANT
Aliceblue ANTInstall and trade smarter everywhere

Entero Healthcare gains 4% after completing majority acquisition of Anand Chemiceutics

News by Aliceblue News Desk

10 Feb 2026

Entero Healthcare gains 4% after completing majority acquisition of Anand Chemiceutics

Introduction

Leading pharmaceutical solutions provider completes acquisition of majority 51.51% stake in Anand Chemiceutics Private Limited, strengthening its business presence and expanding operations in India’s healthcare sector.

Alice Blue Image

Also Read: RMC Switchgears set to move to BSE mainboard after in-principle nod, stock moves 5%

Share price movement of Entero Healthcare

On February 9, 2026, Entero Healthcare Solutions Ltd opened at ₹1,165.05, up 2.52% from its previous close of ₹1,136.75. The stock reached a high of ₹1,177.40 (3.55%) and a low of ₹1,142.15. By 3:05 PM, it traded at ₹1,165.80, a 2.56% increase, with a market cap of ₹5,072.51 crore.

Entero Healthcare Acquires Anand Chemiceutics

Entero Healthcare Solutions Limited has completed the acquisition of a 51.51% majority equity stake in Anand Chemiceutics Private Limited. The acquisition was disclosed under SEBI regulations on November 12, 2025.

The acquisition strengthens Entero Healthcare Solutions’ strategic business portfolio. Details of the transaction were shared as per SEBI Circular SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024, and prior intimation reference 59/SE/LC/2025-26.

Stock performance of Entero Healthcare for Period of 1 week, 6 months, and 1 year

Entero Healthcare Solutions Ltd delivered a 0.93% return over the past week, declined 5.56% in the past 6 months, and fell 20.3% over the past 1 year.

Alice Blue Image

Also Read: Talbros Automotive shares jump after securing multi-year orders worth over ₹1,000 Cr

Shareholding pattern of Entero Healthcare

ParticularsDec 2025Sep 2025Jun 2025
Promoter52.40%52.40%52.40%
FII5.10%14.70%17.20%
DII16.40%9.60%10.20%
Public26.00%23.30%20.20%

About Entero Healthcare

Entero Healthcare Solutions Ltd (NSE: ENTERO) distributes and markets pharmaceutical, surgical products, and allied services in India, providing comprehensive solutions to hospitals, clinics, and healthcare providers since 2018.

Stay Ahead with the Latest Stock Market Updates – Click Here

Disclaimer: The above article is written for educational purposes, and the companies’ data mentioned in the article may change with respect to time. The securities quoted are exemplary and are not recommendatory.

FAQs

Q: Why is Entero Healthcare Solutions Ltd share price rising today?

A: Entero Healthcare Solutions acquires 51.51% stake in Anand Chemiceutics Private Limited.

Q: What is Entero Healthcare Solutions Ltd’s main business focus?

A: Entero Healthcare Solutions Ltd focuses on distribution and marketing of pharmaceutical, surgical products, and allied healthcare services across India.

Q: What are the 52-week high and low of Entero Healthcare Solutions Ltd stock?

A: Entero Healthcare Solutions Ltd stock recorded a 52-week high of ₹1,509.90 and a 52-week low of ₹944.00.

author

News Author

Aliceblue News Desk

Take Your First Step Into The Market With₹0 Opening Charges

Open Free Demat Account
Alice Blue app on two phones